Black Diamond Therapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
Business Address
245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
Mailing Address
245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
Phone
617-417-5868
Fiscal Year End
1231
EIN
814254660
Financial Overview
FY2025
$39.35M
Total Liabilities
$116.74M
Stockholders' Equity
$0.39
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Silevertinib (BDTX-1535) successfully advanced into a Phase 2 clinical trial for recurrent or refractory glioblastoma (GBM) targeting specific EGFR activating mutations.
- BDTX-4933, a potential treatment for EGFR-mutant non-small cell lung cancer (NSCLC), is in preclinical development with an Investigational New Drug (IND) application anticipated in 2025.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.